These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 480887)
21. [The therapy of mesangiocapillary glomerulonephritis]. Ratner MIa; Fedorova ND; Biriukova LS; Makurov AI Ter Arkh; 1995; 67(8):10-2. PubMed ID: 7482319 [TBL] [Abstract][Full Text] [Related]
22. Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study. Futrakul P; Poshyachinda M; Mitrakul C Clin Nephrol; 1978 Nov; 10(5):180-6. PubMed ID: 729213 [TBL] [Abstract][Full Text] [Related]
23. [The effectiveness of cocktail therapy in the early treatment of children with MPGN type I, with special regard to remarkable histological improvement]. Tanizawa T; Miura K; Asada R; Matsukura H; Mase D; Inaba S; Tani M; Hara M; Higuchi A; Okada T Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):401-12. PubMed ID: 3747251 [No Abstract] [Full Text] [Related]
24. [The blood anticoagulant system in rats perorally administered a heparin-acetylsalicylic acid complex]. Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV Izv Akad Nauk SSSR Biol; 1991; (4):625-30. PubMed ID: 1787232 [TBL] [Abstract][Full Text] [Related]
25. [Blood coagulation in chronic bronchopneumopathias. Personal experience with heparin administered in aerosol form]. Molino N; Belluardo C; Molino S Minerva Cardioangiol; 1977 Dec; 25(12):993-8. PubMed ID: 607163 [No Abstract] [Full Text] [Related]
26. [Hemocoagulation processes in the pathogenesis of glomerulonephritis]. Sasinka M; Plenta I; Getlík A; Slugen I; Pavlovic M Cesk Pediatr; 1973 Dec; 28(12):648-52. PubMed ID: 4769674 [No Abstract] [Full Text] [Related]
27. [Treatment of chronic glomerulonephritis with heparin and anticoagulants]. Kinoshita Y; Shimodori T Nihon Rinsho; 1974 Oct; 32(10):3121-5. PubMed ID: 4475171 [No Abstract] [Full Text] [Related]
28. [Combined use of heparin and urokinase in the patients with nephritis resistant to the conventional treatment and the significance of alpha 2-plasmin inhibitor in the therapy (author's transl)]. Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Shimizu K Rinsho Ketsueki; 1982 Mar; 23(3):309-18. PubMed ID: 7050462 [No Abstract] [Full Text] [Related]
29. [Hemostasis suppression by a combination of heparin and acetylsalicylic acid]. Wamhoff D; Schmechel H Z Gesamte Inn Med; 1975 Sep; 30(18):178-80. PubMed ID: 1216936 [TBL] [Abstract][Full Text] [Related]
30. [Mechanisms of the effect of corticosteroid therapy on arterial pressure in chronic glomerulonephritis]. Paleeva FM; Uchitel' IA Sov Med; 1974 Nov; (11):108-13. PubMed ID: 4140573 [No Abstract] [Full Text] [Related]
31. [Criteria for the outcome of treatment of chronic glomerulonephritis and the evaluation of the effectiveness of current therapeutic methods]. Ratner MIa; Tomilina NA; Samokhina NM Ter Arkh; 1978; 50(1):81-7. PubMed ID: 635805 [No Abstract] [Full Text] [Related]
32. [Antithrombotic therapy in correcting hemostatic disorders in patients with chronic glomerulonephritis]. Nazar PS; Badiuk RA Vrach Delo; 1990 Mar; (3):18-20. PubMed ID: 2368351 [TBL] [Abstract][Full Text] [Related]
33. [Use of acetylsalicylic acid in the overall therapy of the severe form of hemorrhagic fever with renal syndrome]. Abdurashitov RF Klin Med (Mosk); 1980 May; 58(5):53-7. PubMed ID: 6103975 [No Abstract] [Full Text] [Related]
34. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis. Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033 [TBL] [Abstract][Full Text] [Related]
35. [Blood phospholipids in patients with different clinical manifestations of chronic glomerulonephritis and preserved kidney function]. Riabov SI; Kulikova AI; Mitrofanova OV Ter Arkh; 1995; 67(2):51-4. PubMed ID: 7725261 [No Abstract] [Full Text] [Related]
36. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Papageorgiou A; Vassiliadis T; Giouleme O; Evgenidis N Aliment Pharmacol Ther; 2006 May; 23(10):1443-53. PubMed ID: 16669959 [TBL] [Abstract][Full Text] [Related]
37. [Pentoxifylline (Trental) in the treatment of chronic glomerulonephritis]. Shoĭkhet IN; Treĭvish VS; Novikova NN Ter Arkh; 1986; 58(8):71-3. PubMed ID: 3764765 [TBL] [Abstract][Full Text] [Related]
38. [Heparin treatment of acute and chronic glomerulonephritis]. Gilunova NI; Tsalenchuk IaP Ter Arkh; 1973 May; 45(5):112-7. PubMed ID: 4768366 [No Abstract] [Full Text] [Related]
39. [Study of the blood coagulation and fibrinolysis systems in evaluating the activity of glomerulonephritis]. Savitskaia IV; Tov NL; Movchan EA; Barkagan LZ; Sidorova LD Klin Med (Mosk); 1989 Feb; 67(2):49-53. PubMed ID: 2724886 [TBL] [Abstract][Full Text] [Related]
40. [Specific features of blood coagulation system and fibrinolysis in patients with glomerulonephritis against the background of heparin treatment]. Panchenko VM; Gilunova NI; Kozhomkulova BZh; Tsitron AI; Liapina LA Klin Med (Mosk); 1977 May; 55(5):116-22. PubMed ID: 875322 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]